60 Day FRN

1580

Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices

outcomes of the program will be in
alignment with CDC/NCEZID strategies
to strengthen and enhance the national
capacity of countries in the Americas to
detect, verify, assess, and respond to
outbreaks and other public health
emergencies of national and
international concern (PHEICs).
The PAHO is in a unique position to
conduct this work, as it was established
in 1902 by President Theodore
Roosevelt and more than three decades
before the United Nations and the
World Health Organization (WHO) as an
international public health agency that
works with the countries of the
Americas to improve the health and
quality of life of their populations.
PAHO is the Regional Office for the
Americas of the WHO as part of the
United Nations system. PAHO’s formal
treaty relationships with all the
ministries of health in the Americas
make it the only organization that can
carry out fully the proposed activities.
WHO and its Regional Offices
(including PAHO) are at the apex of
global public health organizations and
thus have an exclusive status as the
United States government’s key partners
for global public health. The
International Health Regulations (IHR
2005) is an international agreement that
requires WHO Member States to prevent
and respond to acute public health risks
that have the potential to cross borders
and threaten people worldwide.

lotter on DSK11XQN23PROD with NOTICES1

Summary of the Award
Recipient: Pan American Health
Organization (PAHO).
Purpose of the Award: The purpose of
this award is to continue support to
PAHO in developing and implementing
coordinated national and regional
public health programs in the Americas
that are consistent with the World
Health Organization’s International
Health Regulations (IHR) strategies and
the CDC global health priorities, and
better address infectious diseases,
particularly emerging infections.
Strategies and activities include
strengthening and enhancing the
national capacity of countries in the
Americas to detect, verify, assess, and
respond to outbreaks, including
arboviruses, coronaviruses,
chikungunya, dengue, yellow fever,
Zika, HIV, poxviruses, foodborne,
antimicrobial resistant and healthcare
facility-acquired infectious diseases,
and other public health emergencies of
national and international concern
(PHEICs).
Amount of Award: $4,000,000 in
Federal Fiscal Year (FFY) 2023 funds,
with a total estimated $20,000,000 for

VerDate Sep<11>2014

17:17 Jan 10, 2023

Jkt 259001

the 5-year period of performance,
subject to availability of funds.
Authority: This program is authorized
under sections 301 and 307 of the
Public Health Service Act, as amended
[42 U.S.C. 241 and 2421].
Period of Performance: 09/03/2023
through 09/02/2028.
Dated: January 6, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2023–00384 Filed 1–10–23; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–1294; Docket No. CDC–2022–
0143]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Maternal
Mortality Review Information
Application (MMRIA). MMRIA is a
standardized data collection system that
allows Maternal Mortality Review
Committees (MMRCs) to abstract
relevant data from a variety of sources,
document committee decisions, and
analyze data to better understand the
contributing factors and preventability
of pregnancy-related deaths in order to
develop recommendations for
prevention.

SUMMARY:

CDC must receive written
comments on or before March 13, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0143 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
DATES:

PO 00000

Frm 00025

Fmt 4703

Sfmt 4703

Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.

E:\FR\FM\11JAN1.SGM

11JAN1

Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices

lotter on DSK11XQN23PROD with NOTICES1

Proposed Project
The Maternal Mortality Review
Information Application (MMRIA)
(OMB Control No. 0920–1294, Exp. 04/
30/2023)—Revision—National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) seeks a Revision to
continue to collect information through
the Maternal Mortality Review
Information Application (MMRIA) for
three more years. MMRIA is a
standardized data collection system that
allows Maternal Mortality Review
Committees (MMRCs) across the
country to abstract relevant data
(clinical and non-clinical) from a variety
of sources, document committee
decisions, and analyze data in order to
better understand the contributing
factors and preventability of pregnancyrelated deaths and thus to develop
recommendations for prevention.
Pregnancy-related deaths are defined
as a death as a result of pregnancy or
delivery complications, a chain of
events initiated by pregnancy, or the
aggravation of an unrelated condition by
the physiologic effects of pregnancy.
Considerable racial disparities exist,
with persons who are American Indian/
Alaska Native and Black persons two to
three times more likely to die from
pregnancy-related complications than
persons who are White. Findings from
analyses of aggregated MMRC data
indicate that about four out of five
pregnancy-related deaths are
preventable.
Maternal Mortality Review is a
process by which a multidisciplinary
committee at the jurisdiction level
identifies and reviews cases of death
that occur during or within one year of
end of pregnancy. Members of MMRCs
typically represent public health,
obstetrics and gynecology, maternalfetal medicine, nursing, midwifery,
forensic pathology, mental and
behavioral health, community-based
organizations, and other relevant
partners. Through a partnership among
the MMRC, state vital records office,
and epidemiologists, deaths among
females of reproductive age are
examined to determine if they occurred
during pregnancy or within one year of
the end of pregnancy (i.e., pregnancy-

VerDate Sep<11>2014

17:17 Jan 10, 2023

Jkt 259001

associated deaths). Through this
process, potential cases of pregnancyrelated deaths (i.e., death from any
cause related to or aggravated by
pregnancy or its management) are then
identified. Review committees access
multiple sources of clinical and nonclinical information to understand the
circumstances surrounding a death in
order to determine pregnancyrelatedness and develop
recommendations for action to prevent
similar deaths in the future.
MMRIA is a standardized data
collection system designed to support
MMRC processes. Data are abstracted
and entered into MMRIA from various
sources, including death records,
autopsy reports, birth and fetal death
records, prenatal care records,
emergency department visit records,
hospitalization records, records from
other medical office visits, medical
transport records, social and
environmental profiles, mental health
profiles, and informant interviews. Case
narratives for committee reviews are
developed from the abstracted data
entered into MMRIA to facilitate
committee review, and committee
decisions based on their review are also
be entered into MMRIA. The data
collected in MMRIA is used to facilitate
an understanding of the drivers of
maternal mortality and complications of
pregnancy and associated disparities;
determine what interventions at patient,
provider, facility, system, and
community levels will have the most
impact; and implement data driven
recommendations.
The burden estimates presented here
are applicable to the 40 jurisdictions
with funding support through the
cooperative agreements Preventing
Maternal Deaths: Supporting Maternal
Mortality Review Committees (CDC–
RFA–DP19–1908) and Preventing
Maternal Mortality: Supporting
Maternal Mortality Review Committees
CDC–RFA–DP22–2211) which includes
39 direct awardees and one subawardee. These jurisdictions are
required to compile a defined set of
information about pregnancy-related
deaths into MMRIA. It is estimated that
information will be collected for a total
of 1,983 pregnancy-associated deaths on
average, annually, among the 40
jurisdictions with funding support
through CDC–RFA–DP19–1908 and
CDC–RFA–DP22–2211. For 23
jurisdictions, it is estimated that on

PO 00000

Frm 00026

Fmt 4703

Sfmt 4703

1581

average, 15 hours of data abstraction are
required for each death entered into
MMRIA. The other 17 jurisdictions are
able to participate in a process to reduce
burden by which CDC uploads vital
records information into MMRIA rather
than jurisdiction staff manually
abstracting vital records. For these 17
jurisdictions, the estimated average is 14
hours of abstraction for each death
entered into MMRIA. For all
jurisdictions with funding support
through CDC–RFA–DP19–1908 and
CDC–RFA–DP22–2211, an additional 24
minutes on average is needed to enter
the committee decisions into MMRIA.
There are four changes that result in
this request for revision, with the first
three having an impact on the estimated
burden for this revision. First, through
additional congressional appropriations,
an additional 15 jurisdictions are now
funding recipients. This represents an
increase from 24 to 39 funding
recipients. There is a total of 40
respondents, because one funding
recipient provides a subaward to an
additional respondent. Second, CDC
estimates a higher number of pregnancyassociated deaths due to utilizing data
from the Pregnancy Mortality
Surveillance System (PMSS) rather than
CDC WONDER for these estimates.
PMSS estimates of pregnancy-associated
deaths are more accurate due to more
comprehensive and complete
identification of these deaths through
multiple case identification methods.
Third, CDC has been working with the
National Association for Public Health
Statistics and Information Systems on
an initiative that enables CDC to transfer
vital records data associated with CDC
identified pregnancy-associated deaths
directly into a jurisdiction’s instance of
MMRIA, reducing manual data entry
burden for the 17 respondents
participating in the initiative. Fourth, to
address user identified needs and
increase data use for analysis by
jurisdictions, a total of 60 new optional
fields were added to MMRIA, three
fields removed, and two fields
combined. None of the added fields are
required fields.
These changes resulted in an overall
increase to the estimated burden from
the previous approval. CDC requests
OMB approval for an estimated 29,950
annual burden hours. There is no cost
to respondents other than their time to
participate.

E:\FR\FM\11JAN1.SGM

11JAN1

1582

Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent

Jurisdictions with funding support through CDC–RFA–DP19–
1908 and CDC–RFA–DP22–2211 who manually abstract all
data into MMRIA.
Jurisdictions with funding support through CDC–RFA–DP19–
1908 and CDC–RFA–DP22–2211 for which CDC is
uploading vital records into MMRIA and jurisdiction staff abstract remaining data manually into MMRIA.
All jurisdictions with funding support through CDC–RFA–
DP19–1908 and CDC–RFA–DP22–2211.
Total .....................................................................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–00334 Filed 1–10–23; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund the
United Nations Children’s Fund
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $36,000,000 for
Year 1 funding to the United Nations
Children’s Fund (UNICEF). The award
will provide support and vaccines for
supplemental immunization activities
(SIAs) as well as support towards
strengthening of routine immunization
delivery systems and capacities in
developing countries to achieve global
targets for vaccine-preventable disease
(VPD) eradication, elimination, and
reduction. Funding amounts for years
2–5 will be set at continuation.
DATES: The period for this award will be
7/1/2023 through 6/30/2028.
FOR FURTHER INFORMATION CONTACT:
Mary A. Mulholland, Center for Global
Health, Global Immunization Division,
Centers for Disease Control and
Prevention, 1600 Clifton Rd. NE,
Atlanta, GA 30333, Telephone: 404–
553–7371, Email: mmulholland@
cdc.gov.

lotter on DSK11XQN23PROD with NOTICES1

SUMMARY:

VerDate Sep<11>2014

17:17 Jan 10, 2023

Jkt 259001

Number of
respondents

Number of
responses per
respondent

MMRIA data abstraction.

23

50

15

17,250

MMRIA data abstraction.

17

50

14

11,900

MMRIA committee
decisions form.

40

50

0.4

800

....................

........................

....................

29,950

.................................

The
single-source award will support
UNICEF in collaboration with partners
to sustain and strengthen global,
regional and national immunization
program capacity needed to achieve the
globally agreed-upon goals of the
Immunization Agenda 2030 (IA2030),
including polio eradication, elimination
targets for measles, rubella and neonatal
tetanus, and national and subnational
vaccination targets; achieve the 2030
Sustainable Development Goal (SDG) to
end vaccine-preventable deaths among
children under 5 years of age; reduce
chronic disease and cancer deaths from
VPDs; and prevent, detect and respond
to VPD outbreaks.
UNICEF is in a unique position to
conduct this work, as it has a unique
role in the global immunization
partnership as the world’s largest
purchaser of childhood vaccines and
has the primary responsibility for
providing countries with access to highquality, affordable vaccines through
their procurement systems and
distribution networks. UNICEF has
additional roles, including a global
mandate to lead on social mobilization,
community engagement, and other
health communication activities. This
agreement will expand on collaborative
work to detect and respond to vaccine
hesitance and threats to resilience of
demand for vaccines that contribute to
the gap between current global
achievements and global targets.

SUPPLEMENTARY INFORMATION:

Summary of the Award

Frm 00027

Fmt 4703

Sfmt 4703

Total
burden
(in hr)

and strengthening of immunization
systems and capacity in developing
countries, in line with CDC’s Global
Immunization Strategic Framework
(GISF.)
Amount of Award: The approximate
year 1 funding amount will be
$36,000,000 in Federal Fiscal Year
(FYY) 2023 funds, subject to the
availability of funds. Funding amounts
for years 2–5 will be set at continuation.
Authority: This program is authorized
under Section 307 of the PHS Act (42
U.S.C. 242); section 317(k)(1) and (2) of
the PHS Act (42 U.S.C. 247b(k)(1) and
(2).
Period of Performance: 7/1/2023
through 6/30/2028.
Dated: January 6, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2023–00387 Filed 1–10–23; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).

AGENCY:

ACTION:

Recipient: United Nations Children’s
Fund (UNICEF).
Purpose of the Award: The purpose of
this award is to support UNICEF’s
efforts to support polio eradication,
maternal and neonatal tetanus
elimination, and regional measles and
rubella elimination; planning and
implementation of, and demand for,
supplemental immunization campaigns;

PO 00000

Average
burden per
response
(in hr)

Form name

Notice of meeting.

In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Board of
Scientific Counselors, National Center
for Health Statistics (BSC, NCHS). This
meeting is open to the public. Time will
be available for public comment.

SUMMARY:

E:\FR\FM\11JAN1.SGM

11JAN1